Nebula Research & Development LLC Iovance Biotherapeutics, Inc. Transaction History
Nebula Research & Development LLC
- $852 Billion
- Q4 2024
A detailed history of Nebula Research & Development LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 71,964 shares of IOVA stock, worth $269,865. This represents 0.06% of its overall portfolio holdings.
Number of Shares
71,964
Previous 89,790
19.85%
Holding current value
$269,865
Previous $843 Million
36.84%
% of portfolio
0.06%
Previous 0.1%
Shares
4 transactions
Others Institutions Holding IOVA
# of Institutions
343Shares Held
247MCall Options Held
2.51MPut Options Held
3.5M-
Vanguard Group Inc Valley Forge, PA27.5MShares$103 Million0.0% of portfolio
-
Mhr Fund Management LLC New York, NY24.4MShares$91.6 Million24.02% of portfolio
-
Perceptive Advisors LLC New York, NY22.1MShares$82.9 Million5.46% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$79.6 Million0.0% of portfolio
-
State Street Corp Boston, MA12.2MShares$45.9 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $592M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...